Abiopharma

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

HUB25 early-bird pricing ends July 1

Body and Mind Inc. Closes Nevada Divestment

First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm

Annual Reports and Related Documents

BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm

FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm

Cabaletta Bio Announces Pricing of Public Offering of Securities

Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference